HealthAIdir logoHealthAIdir

Behold Red Dot

Conditional
Official website link included
Last reviewed 2026/06/22
Published 2026/06/17

Radiology AI candidate for chest X-ray lung-cancer detection workflows.

Behold Red Dot is a Behold.ai radiology AI product profile anchored on official red dot lung-cancer detection, privacy, and NHS case-study sources. HealthAIdir keeps it conditional pending pricing, security, integration, and market-specific regulatory review.

This page may include affiliate links or demo-request routing. Commercial relationships do not affect HealthAIdir scores, verdicts, rankings, or recommendations.

Introduction

Behold Red Dot is included as a conditional healthcare AI directory profile for radiology AI discovery. The current entry is anchored on Behold.ai's official red dot lung-cancer detection product page, its privacy policy, and an official NHS case study.

HealthAIdir treats this page as a shortlist starting point rather than a final recommendation. Buyers should confirm product scope, deployment model, pricing, privacy terms, security controls, local regulatory status, and implementation responsibilities before using it in a live healthcare workflow.

Best fit

  • International buyers tracking specialty digital health tools
  • Clinical innovation teams building diagnostic AI watchlists
  • Teams that can validate regulatory status in their market

Not a fit

  • Teams that need self-serve pricing and procurement-ready terms immediately
  • Buyers who cannot validate privacy, security, integrations, and deployment scope directly with the vendor

Pros

  • Adds coverage for a relevant healthcare AI or health data workflow area
  • Has a public vendor or ecosystem source to anchor initial review
  • Useful for shortlist discovery before deeper procurement diligence

Cons

  • Pricing was not fully verified during Phase 7 promotion
  • Privacy, security, and compliance pages still need detailed source review
  • Implementation fit depends on local workflow, integrations, and contract terms

Pricing

Pricing summary

No public pricing source was found during the 2026-06-22 Behold source pass; pricing remains unknown and should be confirmed with Behold.ai or an official pricing/procurement page.

Implementation notes

Treat as a candidate until deployment model, radiology workflow fit, pricing, integrations, support model, security controls, and buyer-fit evidence are checked. Confirm whether the intended use is chest X-ray lung-cancer detection, another red dot workflow, or a broader Behold.ai deployment before procurement.

Compliance review

HIPAA

Not reviewed

BAA

Not reviewed

Official Behold.ai product, privacy, and NHS case-study sources are now recorded. No official BAA, SOC 2, HITRUST, HIPAA, public security, or public pricing page was found in this pass, so those claims remain unverified.

Data handling

The official privacy policy is recorded, but it does not by itself establish healthcare deployment terms, PHI retention, access controls, subprocessors, model-training use, or enterprise security commitments for a buyer's workflow.

Integrations

Clinical workflow
Specialty diagnostic systems
Data review workflows

Questions to ask before a demo

Use these questions to turn this profile into a buyer-side evidence checklist. HealthAIdir does not verify production readiness, clinical safety, compliance approval, coding accuracy, billing accuracy, or legal suitability.

  1. 1

    Which healthcare workflow does Behold Red Dot support best?

    Ask the vendor to map supported users, handoffs, review steps, and failure modes to your clinical, revenue cycle, or operations workflow.

  2. 2

    What evidence should be reviewed before a pilot?

    Request source documentation, validation notes, customer scope, update history, and implementation assumptions rather than relying on marketing claims.

  3. 3

    How should the compliance and data handling claims be verified?

    Confirm PHI flow, BAA availability, privacy terms, security controls, audit logs, subprocessors, and whether claims are contractual or only descriptive.

  4. 4

    What integration and implementation work is required?

    Clarify EHR, billing, identity, data export, monitoring, support ownership, training, timeline, and rollback requirements.

  5. 5

    What pricing, contract, and pilot success criteria should be confirmed?

    Review pricing unit, minimum commitments, renewal terms, cancellation, support scope, measurable pilot outcomes, and buyer-side responsibilities.

Related research

Use explicit comparisons and alternative tool profiles to keep shortlist research connected to source evidence.

FAQs

Is Behold Red Dot ready to buy based on this profile alone?
No. This is a conditional seed profile intended for discovery. Pricing, security, privacy, compliance, and implementation evidence should be verified directly from primary vendor or regulatory sources.
Why is Behold Red Dot included in HealthAIdir?
It matches a Phase 7 content gap around interoperability, governance, payer workflow, international digital health, or specialty diagnostics.

Information

Compliance snapshot

  • HIPAANot reviewed
  • BAANot reviewed
  • Editorial disclosure

    HealthAIdir promoted this Phase 7 seed profile from public source research. No vendor paid for placement. Buyers should verify all claims directly with Behold.ai.

  • Editorial boundary

    Featured or sponsor placement does not affect HealthAIdir scores, verdicts, comparisons, or editorial recommendations.

Evidence and sources

Evidence links summarize public source material for traceability. They are not medical, billing, security, HIPAA, BAA, or compliance approval.

Phase 2 Behold source decision 2026-06-22: replaced the failing bare-domain source https://behold.ai/ because TLS hostname validation still fails for that host. Added official Behold.ai source URLs for red dot lung-cancer detection, privacy policy, and an NHS case study. Product, privacy, and case-study evidence are now source-backed; public pricing, public security, BAA, SOC 2, HITRUST, HIPAA, and full deployment data-handling evidence remain unverified. Keep public and conditional; do not assert pricing, regulatory clearance, privacy/security suitability, or clinical-safety claims beyond the...

Show remaining evidence note

listed official source URLs.

Updated 72 days ago from a recorded review event (2026/06/22).

Categories

Tags

Newsletter

Get Healthcare AI Briefings

Monthly procurement notes on clinical AI categories, validation, compliance, and vendor changes.